GlassScriptPhysician profile
Marina Doi
NPI 1699478537
$2,229.70
in general payments reported to CMS, 2019-2025
18 companies · $1,095 in 2025
The $1,095 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $353 · 2024: $782 · 2025: $1,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,229.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.49 | 2024-2025 | |
| Novo Nordisk INC | $307.14 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $258.94 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $231.51 | 2023-2025 | Repatha, Otezla, Krystexxa |
| Lilly USA, LLC | $218.07 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $132.44 | 2024-2025 | |
| Eisai INC. | $122.06 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $91.74 | 2023-2025 | Zoryve, Seglentis, Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $77.89 | 2023-2024 | Trintellix |
| Vertex Pharmaceuticals Incorporated | $62.86 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.17 | 2023-2024 | Xifaxan |
| Exact Sciences Corporation | $50.22 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.68 | 2023-2024 | Jardiance |
| Radius Health, INC. | $28.81 | 2024 | |
| Bioventus LLC | $28.16 | 2023-2024 | Durolane, Durolane |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $22.88 | 2025 | Voquezna |
| Seqirus USA INC | $21.18 | 2025 | Flucelvax, Fluad |
| Esperion Therapeutics, INC. | $17.46 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Doi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.